Details
| Stereochemistry | ABSOLUTE |
| Molecular Formula | C51H72N5O10P |
| Molecular Weight | 946.1186 |
| Optical Activity | UNSPECIFIED |
| Defined Stereocenters | 10 / 10 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
CCOP(=O)(OCC)[C@H](NC(=O)[C@]1(O)[C@@H]2N(C)C3=CC(OC)=C(C=C3[C@@]24CCN5CC=C[C@](CC)([C@@H]45)[C@H]1O)[C@]6(C[C@H]7CN(C[C@](O)(CC)C7)CCC8=C6NC9=C8C=CC=C9)C(=O)OC)C(C)C
InChI
InChIKey=BOELCLFVOBIXIF-MAKKXPIGSA-N
InChI=1S/C51H72N5O10P/c1-10-47(60)27-32-28-50(46(59)64-9,40-34(19-23-55(29-32)30-47)33-17-14-15-18-37(33)52-40)36-25-35-38(26-39(36)63-8)54(7)43-49(35)21-24-56-22-16-20-48(11-2,42(49)56)44(57)51(43,61)45(58)53-41(31(5)6)67(62,65-12-3)66-13-4/h14-18,20,25-26,31-32,41-44,52,57,60-61H,10-13,19,21-24,27-30H2,1-9H3,(H,53,58)/t32-,41-,42-,43+,44+,47-,48+,49+,50-,51-/m0/s1
| Molecular Formula | C51H72N5O10P |
| Molecular Weight | 946.1186 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ABSOLUTE |
| Additional Stereochemistry | No |
| Defined Stereocenters | 10 / 10 |
| E/Z Centers | 0 |
| Optical Activity | UNSPECIFIED |
DescriptionSources: https://www.ncbi.nlm.nih.gov/pubmed/7882462
Sources: https://www.ncbi.nlm.nih.gov/pubmed/7882462
Vinfosiltine (also known as S 12363) was developed as a vinca alkaloid derivative. It is known that vinca alkaloids are widely used in the medical treatment of breast cancer. Vinfosiltine participated in the phase II clinical trial to treat the patients with advanced breast cancer. The results have shown that the drug didn’t have significant single-agent activity. As a result, the development of vinfosiltine was discontinued.
Approval Year
Sample Use Guides
In Vivo Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/7882462
a randomization was performed between two schedules with the same dose intensity, that is, 0.3 mg/m2 given weekly or 0.6 mg/m2 given every 2 weeks
Route of Administration:
Intravenous
| Substance Class |
Chemical
Created
by
admin
on
Edited
Mon Mar 31 18:52:44 GMT 2025
by
admin
on
Mon Mar 31 18:52:44 GMT 2025
|
| Record UNII |
AW1UYE6Q9I
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Official Name | English | ||
|
Preferred Name | English | ||
|
Common Name | English |
| Classification Tree | Code System | Code | ||
|---|---|---|---|---|
|
NCI_THESAURUS |
C932
Created by
admin on Mon Mar 31 18:52:44 GMT 2025 , Edited by admin on Mon Mar 31 18:52:44 GMT 2025
|
||
|
NCI_THESAURUS |
C67422
Created by
admin on Mon Mar 31 18:52:44 GMT 2025 , Edited by admin on Mon Mar 31 18:52:44 GMT 2025
|
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
CHEMBL2103757
Created by
admin on Mon Mar 31 18:52:44 GMT 2025 , Edited by admin on Mon Mar 31 18:52:44 GMT 2025
|
PRIMARY | |||
|
DTXSID10153930
Created by
admin on Mon Mar 31 18:52:44 GMT 2025 , Edited by admin on Mon Mar 31 18:52:44 GMT 2025
|
PRIMARY | |||
|
70691387
Created by
admin on Mon Mar 31 18:52:44 GMT 2025 , Edited by admin on Mon Mar 31 18:52:44 GMT 2025
|
PRIMARY | |||
|
100000079092
Created by
admin on Mon Mar 31 18:52:44 GMT 2025 , Edited by admin on Mon Mar 31 18:52:44 GMT 2025
|
PRIMARY | |||
|
AW1UYE6Q9I
Created by
admin on Mon Mar 31 18:52:44 GMT 2025 , Edited by admin on Mon Mar 31 18:52:44 GMT 2025
|
PRIMARY | |||
|
SUB00065MIG
Created by
admin on Mon Mar 31 18:52:44 GMT 2025 , Edited by admin on Mon Mar 31 18:52:44 GMT 2025
|
PRIMARY | |||
|
C2378
Created by
admin on Mon Mar 31 18:52:44 GMT 2025 , Edited by admin on Mon Mar 31 18:52:44 GMT 2025
|
PRIMARY | |||
|
6735
Created by
admin on Mon Mar 31 18:52:44 GMT 2025 , Edited by admin on Mon Mar 31 18:52:44 GMT 2025
|
PRIMARY | |||
|
123286-00-0
Created by
admin on Mon Mar 31 18:52:44 GMT 2025 , Edited by admin on Mon Mar 31 18:52:44 GMT 2025
|
PRIMARY |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
SALT/SOLVATE -> PARENT |
|
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
ACTIVE MOIETY |
|